Cargando…

Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial

OBJECTIVE: The goal for this study was to evaluate the effects of daily consumption of Puer tea extract (PTE) on body weight, body-fat composition, and lipid profile in a non-Asian population in the absence of dietary restrictions. MATERIALS AND METHODS: A randomized, double-blind, placebo-controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Gitte S, Beaman, Joni L, He, Yi, Guo, Zhixin, Sun, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818050/
https://www.ncbi.nlm.nih.gov/pubmed/27069360
http://dx.doi.org/10.2147/CIA.S94881
_version_ 1782424964560846848
author Jensen, Gitte S
Beaman, Joni L
He, Yi
Guo, Zhixin
Sun, Henry
author_facet Jensen, Gitte S
Beaman, Joni L
He, Yi
Guo, Zhixin
Sun, Henry
author_sort Jensen, Gitte S
collection PubMed
description OBJECTIVE: The goal for this study was to evaluate the effects of daily consumption of Puer tea extract (PTE) on body weight, body-fat composition, and lipid profile in a non-Asian population in the absence of dietary restrictions. MATERIALS AND METHODS: A randomized, double-blind, placebo-controlled study design was used. A total of 59 overweight or mildly obese subjects were enrolled upon screening to confirm fasting cholesterol level at or above 220 mg/dL (5.7 mmol/dL). After giving informed consent, subjects were randomized to consume PTE (3 g/day) or placebo for 20 weeks. At baseline and at 4-week intervals, blood lipids, C-reactive protein, and fasting blood glucose were evaluated. A dual-energy X-ray absorptiometry scan was performed at baseline and at study exit to evaluate changes to body composition. Appetite and physical and mental energy were scored at each visit using visual analog scales (0–100). RESULTS: Consumption of PTE was associated with statistically significant weight loss when compared to placebo (P<0.05). Fat loss was seen for arms, legs, and the gynoid region (hip/belly), as well as for total fat mass. The fat reduction reached significance on within-group analysis, but did not reach between-group significance. Consumption of PTE was associated with improvements to lipid profile, including a mild reduction in cholesterol and the cholesterol:high-density lipoprotein ratio after only 4 weeks, as well as a reduction in triglycerides and very small-density lipoproteins, where average blood levels reached normal range at 8 weeks and remained within normal range for the duration of the study (P<0.08). No significant changes between the PTE group and the placebo group were seen for fasting glucose or C-reactive protein. A transient reduction in appetite was seen in the PTE group when compared to placebo (P<0.1). CONCLUSION: The results from this clinical study showed that the daily consumption of PTE was associated with significant weight loss, reduced body mass index, and an improved lipid profile.
format Online
Article
Text
id pubmed-4818050
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48180502016-04-11 Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial Jensen, Gitte S Beaman, Joni L He, Yi Guo, Zhixin Sun, Henry Clin Interv Aging Original Research OBJECTIVE: The goal for this study was to evaluate the effects of daily consumption of Puer tea extract (PTE) on body weight, body-fat composition, and lipid profile in a non-Asian population in the absence of dietary restrictions. MATERIALS AND METHODS: A randomized, double-blind, placebo-controlled study design was used. A total of 59 overweight or mildly obese subjects were enrolled upon screening to confirm fasting cholesterol level at or above 220 mg/dL (5.7 mmol/dL). After giving informed consent, subjects were randomized to consume PTE (3 g/day) or placebo for 20 weeks. At baseline and at 4-week intervals, blood lipids, C-reactive protein, and fasting blood glucose were evaluated. A dual-energy X-ray absorptiometry scan was performed at baseline and at study exit to evaluate changes to body composition. Appetite and physical and mental energy were scored at each visit using visual analog scales (0–100). RESULTS: Consumption of PTE was associated with statistically significant weight loss when compared to placebo (P<0.05). Fat loss was seen for arms, legs, and the gynoid region (hip/belly), as well as for total fat mass. The fat reduction reached significance on within-group analysis, but did not reach between-group significance. Consumption of PTE was associated with improvements to lipid profile, including a mild reduction in cholesterol and the cholesterol:high-density lipoprotein ratio after only 4 weeks, as well as a reduction in triglycerides and very small-density lipoproteins, where average blood levels reached normal range at 8 weeks and remained within normal range for the duration of the study (P<0.08). No significant changes between the PTE group and the placebo group were seen for fasting glucose or C-reactive protein. A transient reduction in appetite was seen in the PTE group when compared to placebo (P<0.1). CONCLUSION: The results from this clinical study showed that the daily consumption of PTE was associated with significant weight loss, reduced body mass index, and an improved lipid profile. Dove Medical Press 2016-03-24 /pmc/articles/PMC4818050/ /pubmed/27069360 http://dx.doi.org/10.2147/CIA.S94881 Text en © 2016 Jensen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Jensen, Gitte S
Beaman, Joni L
He, Yi
Guo, Zhixin
Sun, Henry
Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial
title Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial
title_full Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial
title_fullStr Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial
title_full_unstemmed Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial
title_short Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial
title_sort reduction of body fat and improved lipid profile associated with daily consumption of a puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818050/
https://www.ncbi.nlm.nih.gov/pubmed/27069360
http://dx.doi.org/10.2147/CIA.S94881
work_keys_str_mv AT jensengittes reductionofbodyfatandimprovedlipidprofileassociatedwithdailyconsumptionofapuerteaextractinahyperlipidemicpopulationarandomizedplacebocontrolledtrial
AT beamanjonil reductionofbodyfatandimprovedlipidprofileassociatedwithdailyconsumptionofapuerteaextractinahyperlipidemicpopulationarandomizedplacebocontrolledtrial
AT heyi reductionofbodyfatandimprovedlipidprofileassociatedwithdailyconsumptionofapuerteaextractinahyperlipidemicpopulationarandomizedplacebocontrolledtrial
AT guozhixin reductionofbodyfatandimprovedlipidprofileassociatedwithdailyconsumptionofapuerteaextractinahyperlipidemicpopulationarandomizedplacebocontrolledtrial
AT sunhenry reductionofbodyfatandimprovedlipidprofileassociatedwithdailyconsumptionofapuerteaextractinahyperlipidemicpopulationarandomizedplacebocontrolledtrial